Difference between revisions of "Vendor:Canadian Clinical Cannabinoids, Inc."
From LIMSWiki
Jump to navigationJump to searchShawndouglas (talk | contribs) (Created as needed.) |
Shawndouglas (talk | contribs) (Created as needed) |
||
| Line 1: | Line 1: | ||
{{ | {{Infobox company | ||
== | |company_name = '''Canadian Clinical Cannabinoids, Inc.''' | ||
|company_logo = | |||
|company_type = Incorporated (inc.) | |||
|traded_as = | |||
|industry = Manufacturing, analytical testing | |||
|genre = | |||
|fate = | |||
|predecessor = | |||
|successor = | |||
|company_slogan = | |||
|foundation = | |||
|founder = | |||
|defunct = | |||
|location_city = 1 Front Street, Toronto, Ontario | |||
|location_country = Canada | |||
|locations = 1 | |||
|area_served = Canada | |||
|key_people = | |||
|products = | |||
|production = | |||
|services = Manufacturing, ''Cannabis'' testing | |||
|revenue = | |||
|operating_income = | |||
|net_income = | |||
|aum = | |||
|assets = | |||
|equity = | |||
|owner = | |||
|num_employees = | |||
|parent = Supreme Cannabis Company, Inc.<ref name="BiospaceSupremen19">{{cite web |url=https://www.biospace.com/article/releases/supreme-cannabis-to-acquire-truverra-as-it-prepares-for-legalization-2-0-and-global-medical-markets/l |title=Supreme Cannabis to acquire Truverra as it prepares for Legalization 2.0 and Global Medical Markets |work=BioSpace |date=17 July 2019 |accessdate=03 January 2020}}</ref> | |||
|divisions = | |||
|subsid = | |||
|homepage = [http://www.cccmedical.com/ cccmedical.com] | |||
|linkedin = [https://www.linkedin.com/company/canadianclinicalcannabinoids https://www.linkedin.com/company/canadianclinicalcannabinoids] | |||
|footnotes = | |||
|intl = No | |||
}} | |||
'''Canadian Clinical Cannabinoids, Inc.''' ('''CCC''') manufactures ''[[Cannabis]]''-based extracts and is licensed to performs chemical ''Cannabis'' laboratory testing for the country's various cannabis programs.<ref name="GoCLab18">{{cite web |url=https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html |title=Laboratories licensed to conduct activities with cannabis |work=Health Canada |publisher=Government of Canada |date=13 December 2019 |accessdate=03 January 2020}}</ref> | |||
==History== | |||
The company was founded in November 2013.<ref name="CACLACan">{{cite web |url=https://beta.canadasbusinessregistries.ca/search/results?search={Canadian%20Clinical%20Cannabinoids%20Inc.}&status=All |title=Canadian Clinical Cannabinoids, Inc |work=Canada's Business Registries |publisher=Canadian Association of Corporate Law Administrators |accessdate=03 January 2020}}</ref> In July 2019, Supreme Cannabis Company, Inc. acquired Truverra, Inc., the parent company of CCC. A press release announced that "Supreme Cannabis intends to repurpose CCC's state-of-the-art facility to produce high-quality cannabis extracts, including concentrates and vaping liquids."<ref name="BiospaceSupremen19" /> In September 2019, CCC acquired its license to analyze ''Cannabis''.<ref name="GoCLab18" /> | |||
==Locations== | |||
The following laboratory locations are known. Services may vary among locations: | |||
* [https://truverra.com/contact-us/ Canadian Clinical Cannabinoids] - Toronto, Ontario | |||
==Pricing== | |||
The company doesn't make its cannabis testing pricing public. | |||
==Additional information== | |||
* [https://truverra.com/ Truverra, Inc.], the former parent of CCC | |||
==References== | |||
<references/> | |||
<!---Place all category tags here--> | <!---Place all category tags here--> | ||
[[Category:Cannabis testing laboratories]] | [[Category:Cannabis testing laboratories]] | ||
[[Category:Labs in Canada]] | [[Category:Labs in Canada]] | ||
[[Category:Labs in Ontario]] | |||
[[Category:Vendors]] | |||
Revision as of 17:19, 3 December 2023
| Type | Incorporated (inc.) |
|---|---|
| Industry | Manufacturing, analytical testing |
| Headquarters | 1 Front Street, Toronto, Ontario, Canada |
| Number of locations | 1 |
| Area served | Canada |
| Services | Manufacturing, Cannabis testing |
| Parent | Supreme Cannabis Company, Inc.[1] |
| Website | cccmedical.com |
| https://www.linkedin.com/company/canadianclinicalcannabinoids |
Canadian Clinical Cannabinoids, Inc. (CCC) manufactures Cannabis-based extracts and is licensed to performs chemical Cannabis laboratory testing for the country's various cannabis programs.[2]
History
The company was founded in November 2013.[3] In July 2019, Supreme Cannabis Company, Inc. acquired Truverra, Inc., the parent company of CCC. A press release announced that "Supreme Cannabis intends to repurpose CCC's state-of-the-art facility to produce high-quality cannabis extracts, including concentrates and vaping liquids."[1] In September 2019, CCC acquired its license to analyze Cannabis.[2]
Locations
The following laboratory locations are known. Services may vary among locations:
- Canadian Clinical Cannabinoids - Toronto, Ontario
Pricing
The company doesn't make its cannabis testing pricing public.
Additional information
- Truverra, Inc., the former parent of CCC
References
- ↑ 1.0 1.1 "Supreme Cannabis to acquire Truverra as it prepares for Legalization 2.0 and Global Medical Markets". BioSpace. 17 July 2019. https://www.biospace.com/article/releases/supreme-cannabis-to-acquire-truverra-as-it-prepares-for-legalization-2-0-and-global-medical-markets/l. Retrieved 03 January 2020.
- ↑ 2.0 2.1 "Laboratories licensed to conduct activities with cannabis". Health Canada. Government of Canada. 13 December 2019. https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html. Retrieved 03 January 2020.
- ↑ "Canadian Clinical Cannabinoids, Inc". Canada's Business Registries. Canadian Association of Corporate Law Administrators. https://beta.canadasbusinessregistries.ca/search/results?search={Canadian%20Clinical%20Cannabinoids%20Inc.}&status=All. Retrieved 03 January 2020.
